Showing results (471-480 of 606) with videos related to
Sort By:
Pageof 61
The Annals of Thoracic Surgery|July 1, 1994
Predictive value of blood clotting tests in cardiac surgical patientsG P Gravlee, S Arora, S W Lavender, et al.American Journal of Clinical Oncology|October 1, 1983
Vincristine by continuous infusion in refractory breast cancer: a phase II studyJ O Hopkins, D V Jackson, D R White, et al.American Journal of Clinical Oncology|June 1, 1983
Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213D V Jackson, H B Wells, D R White, et al.Journal of Medical Genetics|September 3, 2002
Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2)I A Aligianis, T Forshew, S Johnson, et al.Journal of Medicinal Chemistry|March 15, 1996
Lipophilic antifolates as agents against opportunistic infections. 1. Agents superior to trimetrexate and piritrexim against Toxoplasma gondii and Pneumocystis carinii in in vitro evaluationsJ R Piper, C A Johnson, C A Krauth, et al.The Journal of Biological Chemistry|July 21, 1998
Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell lineL A Barber, D F Spandau, S C Rathman, et al.Headache|June 1, 1992
The relationship of ovarian steroids, headache activity and menstrual distress: a pilot study with female migraineursJ C Beckham, L M Krug, D B Penzien, et al.Addictive Behaviors|January 1, 1989
The television, school and family smoking prevention/cessation project. IV. Controlling for program success expectancies across experimental and control conditionsS Sussman, C W Dent, B R Brannon, et al.Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|January 1, 1987
Path model of multidimensional compliance with cancer therapyJ L Richardson, G Marks, C A Johnson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1986
Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology AssociationF Richards, L D Case, D R White, et al.Pageof 61